King’s College London R&D
King’s College London R&D
Please use this area of the website to help you find out more information about the R&D office and it’s processes.
- Guidance on Sponsorship
- Guidance for R&D Approval
- Looking for Funding? (resources for staff and students)
- Guidance on applying for research grants
- Research Passports
Kings College London links
Below are some links to the wider Kings College London website that you may find useful
Research Portal – search the King’s College London research database
If your study is sponsored by a commercial organisation you will need to contact the KHP Clinical Trials Office (opens in new window), who will undertake the administration and contract negotiations for these studies.
NIHR Portfolio – CSP
If your funder is eligible to be part of the NIHR CRN Portfolio (these include the Research Councils, most large national medical research charities, government departments and EU. For full details see http://www.ukcrn.org.uk/index/clinical/portfolio_new/P_eligibility.html) and your study involves SLaM patients or staff, then your approval will be organised via the National Institute for Health Research Coordinated System for gaining NHS Permissions (NIHR CSP). It is essential that this route is used for all of these studies as this is the only mechanism for the Trust to receive the support funding for your research. Further details on the process for CSP are available from the R&D Office (email@example.com 020 7848 0251).
Applications for NHS Permission through NIHR CSP must be made via the Integrated Research Application System (IRAS). (Opens in new window). Researchers who have started to complete applications in IRAS but have not yet made applications to R&D offices should contact the NIHR CSP Unit at firstname.lastname@example.org for guidance. If you bypass this route for eligible funders in error, the R&D Office will have to return your application to you for CSP submission which will delay the process.
If your study does not fall under either of the categories above, please follow the guidance below on how to obtain R&D approval within SLaM.
Documents to be submitted for R&D approval (all studies)
You will need to submit the following to the R&D Office when applying for R&D approval:
- The IRAS NHS R&D Form and SSI Form
- All documents listed on the IRAS checklists for the R&D and SSI forms
- SLaM R&D Approval cover sheet – this form is available below, together with guidance on completing the form
- If your study is a Clinical Trial of an Investigational Medicinal Product (CTIMP) or involves the use of a drug, you must submit an electronic copy of your protocol for a risk assessment
- Evidence that proper Human Resources and access arrangements have been made with SLaM in respect of the researchers who will be performing research activities on your study. Please refer to our Research Passport section for more information about the arrangements
- Final approval letter from the Ethics Committee (REC) and copies of the final REC-approved documents. R&D Approval will not be given until full ethics approval has been received for the study
- Information sheets and consent forms on SLaM- headed paper with up to date local contact information.
CTIMPs have additional legal requirements. Please refer to our Clinical Trials page for further information.
Guidance and Important Documents (available as downloads)
- KCL/SLaM Sponsorship Guidance
- KCL/SLaM Sponsorship Guidance for HRA Approval
- KCL/SLaM Sponsorship Guide (Appendix for Students)
- Sponsorship Guidance Appendix A – Protocol Guidance
- Sponsorship Guidance Appendix B – Peer-Review
- Sponsorship Guidance Appendix C – Risk Assessment
- Sponsorship Guidance Appendix D – Tissue
- Sponsorship Guidance Appendix E – Local service and facilities
- Sponsorship Guidance Appendix F – Training and Resources
- As from 01/04/2009 the responsibility for Site Specific Approval for NHS sites moved from Ethics Committees to R&D Offices. For further information click here.
- Site Specific Approval for non-NHS sites is required and will be considered by an NHS REC for clinical trials and investigations and studies involving adults with incapacity. Guidance will be provided when booking into an ethics committee and confirmed in the REC validation letter.
All research involving the NHS patients must have ethical approval from an NHS Research Ethics Committee (REC) before it can begin. Please see our Ethical Approval page for further information.
The involvement of service users and the public is a key element of the Research Governance Framework. There is a group established called The Service Users Research Enterprise (SURE) which supports this within SL&M/IoP. In addition there is a group entitled the Consumers in Research Advisory Group (CRAG) which provides support to service users who sit on the R&D Steering Group. More information regarding these groups or directly from the SURE webpages.